An EconoTimes perspective

Yasmina Molero

Researcher, Department of Clinical Neuroscience and Department of Medical Epidemiology and Biostatistics, Karolinska Institutet

Researcher, Department of Clinical Neuroscience and Department of Medical Epidemiology and Biostatistics, Karolinska Institutet I am a researcher at the Department of Clinical Neuroscience and the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet. I obtained my PhD at Karolinska Institutet and completed postdoctoral fellowships at the University of Oxford and at Karolinska Institutet. My research is mostly focused on pharmacoepidemiology. That is, I study the risks and benefits of common medications with a specific interest in psychiatric and behavioural outcomes such as depression, anxiety, suicide, overdoses, accidents, violence and other crimes. For this, I use Swedish pharmacy, healthcare, sociodemographic, crime and death registers, and I study nationwide cohorts of people who take different medications. I have previously published studies on the psychiatric and behavioural outcomes of antidepressants, nicotine replacement therapy, antiepileptic drugs, cholesterol-lowering medications, and medications for treating substance use disorders.